A woman with three different autoimmune conditions had all of them treated simultaneously by genetically modifying her immune ...
CAR-T cell therapy puts woman's three autoimmune diseases into remission after single infusion when nine previous treatments ...
CAR-T therapy has transformed treatment for some blood cancers, with seven FDA-approved products and strong clinical responses in hematologic malignancies.
A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, ...
Cancers that were once considered incurable now have new treatment options. Among these innovations are CAR-T (chimeric ...
MINNEAPOLIS — Chimeric antigen receptor (CAR) T-cell therapy in children with certain rheumatologic conditions appears to be ...
CAR-T cell therapy represents an innovative form of immunotherapy, wherein T cells are genetically modified to recognize and ...
Over the last decade, the cellular cancer immunotherapy known as CAR T-cell therapy has roared to the rescue of many blood cancer patients. The engineered immune cells revolutionized treatment of ...
CAR T-cell therapy shows promise for SCLC, but significant barriers, such as tumor heterogeneity and immunosuppression, must be addressed. Identifying tumor-selective antigens like CDH17, GD2, and ...
ORLANDO -- A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable residual disease (MRD)-negative responses in the first four patients with relapsed ...
T-cell therapy has transformed the treatment landscape for patients with relapsed or refractory large B-cell lymphoma (LBCL), ...
Researchers from the Keck School of Medicine of USC have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response to cancer in mice—effectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results